indole-2-carboxylic acid has been researched along with navitoclax in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, DJ; Bruncko, M; Chen, J; Eastham-Anderson, J; Elmore, SW; Fairbrother, WJ; Gierke, S; Jin, S; Kategaya, L; Kovar, P; Leverson, JD; Ludlam, MJ; Nimmer, P; Phillips, DC; Rosenberg, SH; Sampath, D; Sheppard, GS; Smith, M; Souers, AJ; Tahir, SK; Tanaka, A; Tse, C; Wang, L; Wertz, I; Wong, C; Xiao, Y; Xue, J; Zhang, H | 1 |
Anantram, A; Degani, M | 1 |
1 review(s) available for indole-2-carboxylic acid and navitoclax
Article | Year |
---|---|
Targeting cancer's Achilles' heel: role of BCL-2 inhibitors in cellular senescence and apoptosis.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Arylsulfonates; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Carboxylic Acids; Cell Line, Tumor; Cellular Senescence; Drug Screening Assays, Antitumor; Gene Expression Regulation; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxyquinolines; Indoles; Molecular Structure; Molecular Targeted Therapy; Myeloid Cell Leukemia Sequence 1 Protein; Protein Binding; Protein Conformation; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Pyrogallol; Pyrroles; Salicylates; Structure-Activity Relationship; Sulfonamides | 2019 |
1 other study(ies) available for indole-2-carboxylic acid and navitoclax
Article | Year |
---|---|
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
Topics: Aniline Compounds; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Indoles; Membrane Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms; Proto-Oncogene Proteins; Small Molecule Libraries; Sulfonamides | 2015 |